Article Text

Download PDFPDF

GRP-087 Impact of an Electronic Medicines Reconciliation Programme Used in a General Surgery Unit
  1. A Giménez Manzorro1,
  2. C Pérez Sanz1,
  3. R Romero Jiménez1,
  4. P Bodas Gutiérrez2,
  5. MJ Planelles López2,
  6. R Pla Mestre3,
  7. JM Bellón4,
  8. A Herranz Alonso1,
  9. M Sanjurjo Sáez1
  1. 1Hospital General Universitario Gregorio Marañon, Pharmacy Service, Madrid, Spain
  2. 2Hospital General Universitario Gregorio Marañon, General Surgery Service, Madrid, Spain
  3. 3Hospital General Universitario Gregorio Marañon, Preventive Medicine Service, Madrid, Spain
  4. 4Hospital General Universitario Gregorio Marañon, Statistics Service, Madrid, Spain


Background Medicines reconciliation is a key tool in the prevention of adverse drug events.

Purpose To assess the impact of a medicines reconciliation programme for hospital admission into a general surgery unit, including an electronic tool, in the number and type of unintended discrepancies between chronic medicines and medicines prescribed upon admission.

Materials and Methods A quasi-experimental/retrospective study was carried out, analysing discrepancies between chronic medicines and drugs prescribed in the hospital, before and after a medicines reconciliation programme was implemented.

Patients admitted into a general surgery unit for more than 24 h who were taking ≥3 drugs chronically at home were included.

A standardised interview was conducted to record chronic medicines. Pharmacists detected and investigated discrepancies. The severity of unintended discrepancies was assessed by consensus with medical staff using the National Coordinating Council for Medication Error Reporting and Prevention 2001 classification. A computerised reconciliation tool, integrated into the electronic prescription, was implemented during the intervention phase.

Results A total of 191 patients were included (52.9% male, 47.1% female), 107 patients in the phase before intervention and 84 in the phase after intervention.

1,951 drugs were investigated, and 1,678 discrepancies were detected. There were 167 unintended discrepancies, 102 (10.6% of drugs investigated) in the first phase and 65 in the second phase (6.6%), p = 0.0021. Omission of drugs was the most common unintended discrepancy, being 89 (9.2%) in the phase before and 55 (5.6%) in the phase after intervention, p = 0.0027.

Unintended discrepancies were grade C severity in 79.2% of those detected, decreasing in the second phase (3.95% of total drugs investigated) compared to the first one (8.61%), p < 0.05.

Conclusions The implementation of the medicines reconciliation programme has shown a reduction of the rate of unintended discrepancies detected during admission into a general surgery unit. Omission of drugs was the most common type of discrepancy detected in both phases and decreased after intervention.

No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.